145 related articles for article (PubMed ID: 38363910)
21. A novel MRI-based deep learning networks combined with attention mechanism for predicting CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma.
Zhang L; Wang R; Gao J; Tang Y; Xu X; Kan Y; Cao X; Wen Z; Liu Z; Cui S; Li Y
Eur Radiol; 2024 Jan; 34(1):391-399. PubMed ID: 37553486
[TBL] [Abstract][Full Text] [Related]
22. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
23. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
[TBL] [Abstract][Full Text] [Related]
24. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
[TBL] [Abstract][Full Text] [Related]
25. [A Dual-Aware deep learning framework for identification of glioma isocitrate dehydrogenase genotype using magnetic resonance amide proton transfer modalities].
Chu Z; Qu Y; Zhong T; Liang S; Wen Z; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1379-1387. PubMed ID: 37712275
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
27. Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas.
Nishikawa T; Ohka F; Aoki K; Suzuki H; Motomura K; Yamaguchi J; Maeda S; Kibe Y; Shimizu H; Natsume A; Innan H; Saito R
Brain Tumor Pathol; 2023 Apr; 40(2):85-92. PubMed ID: 36991274
[TBL] [Abstract][Full Text] [Related]
28. Deep semi-supervised learning for brain tumor classification.
Ge C; Gu IY; Jakola AS; Yang J
BMC Med Imaging; 2020 Jul; 20(1):87. PubMed ID: 32727476
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
[TBL] [Abstract][Full Text] [Related]
30. Residual Convolutional Neural Network for the Determination of
Chang K; Bai HX; Zhou H; Su C; Bi WL; Agbodza E; Kavouridis VK; Senders JT; Boaro A; Beers A; Zhang B; Capellini A; Liao W; Shen Q; Li X; Xiao B; Cryan J; Ramkissoon S; Ramkissoon L; Ligon K; Wen PY; Bindra RS; Woo J; Arnaout O; Gerstner ER; Zhang PJ; Rosen BR; Yang L; Huang RY; Kalpathy-Cramer J
Clin Cancer Res; 2018 Mar; 24(5):1073-1081. PubMed ID: 29167275
[No Abstract] [Full Text] [Related]
31. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
[TBL] [Abstract][Full Text] [Related]
32. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
33. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Li Z; Zhao W; He B; Koh TS; Li Y; Zeng Y; Zhang Z; Zhang J; Hou Z
Contrast Media Mol Imaging; 2020; 2020():8843084. PubMed ID: 33299387
[TBL] [Abstract][Full Text] [Related]
34. Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.
Michiwaki Y; Hata N; Mizoguchi M; Hiwatashi A; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Togao O; Suzuki SO; Yoshimoto K; Iwaki T; Iihara K
Clin Neurol Neurosurg; 2019 Dec; 187():105556. PubMed ID: 31639630
[TBL] [Abstract][Full Text] [Related]
35. Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
Jian A; Jang K; Manuguerra M; Liu S; Magnussen J; Di Ieva A
Neurosurgery; 2021 Jun; 89(1):31-44. PubMed ID: 33826716
[TBL] [Abstract][Full Text] [Related]
36. Static
Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
[TBL] [Abstract][Full Text] [Related]
37. Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
Low SK; Anjum Z; Mahmoud A; Joshi U; Kouides P
Thromb Res; 2022 Nov; 219():14-21. PubMed ID: 36088710
[TBL] [Abstract][Full Text] [Related]
38. A multimodal domain adaptive segmentation framework for IDH genotype prediction.
Zeng H; Xing Z; Gao F; Wu Z; Huang W; Su Y; Chen Z; Cai S; Cao D; Cai C
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1923-1931. PubMed ID: 35794409
[TBL] [Abstract][Full Text] [Related]
39. Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
Eur Radiol; 2019 Feb; 29(2):745-758. PubMed ID: 30003316
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.
Zhou M; Zhou Y; Liao H; Rowland BC; Kong X; Arvold ND; Reardon DA; Wen PY; Lin AP; Huang RY
Neuro Oncol; 2018 Aug; 20(9):1262-1271. PubMed ID: 29438510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
